Inventor · disambiguated record
Campbell Mcinnes
Also filed as: MCINNES CAMPBELL
17 granted patents·16 pending applications·86 citations·filing 2000–2023
92Inventor score
Top patents by PatentIndex Score
33 records- 0189US8566072B2Cyclin based inhibitors of CDK2 and CDK4MCINNES CAMPBELL·Filed 2011·Granted Oct 22, 2013·11 cites·17 claims
- 0288US7897605B2Pyrimidine compoundsCYCLACEL LTD·Filed 2008·Granted Mar 1, 2011·14 cites·6 claims
- 0386US10067131B2Fragment ligated inhibitors selective for the polo box domain of PLK1UNIV SOUTH CAROLINA·Filed 2015·Granted Sep 4, 2018·4 cites·5 claims
- 0485US11014906B2Quinoline-based compounds and methods of inhibiting CDK8/19UNIV SOUTH CAROLINA·Filed 2019·Granted May 25, 2021·3 cites·19 claims
- 0585US9376465B2Cyclin based inhibitors of CDK2 and CDK4UNIV SOUTH CAROLINA·Filed 2014·Granted Jun 28, 2016·5 cites·1 claims
- 0682US9982015B2Cyclin based inhibitors of CDK2 and CDK4UNIV SOUTH CAROLINA·Filed 2016·Granted May 29, 2018·4 cites·5 claims
- 0781US9328139B2Cyclin based inhibitors of CDK2 and CDK4MCINNES CAMPBELL·Filed 2013·Granted May 3, 2016·4 cites·3 claims
- 0880US9175357B2Fragment ligated inhibitors selective for the polo box domain of PLK1MCINNES CAMPBELL·Filed 2012·Granted Nov 3, 2015·4 cites·8 claims
- 0980US7576091B2Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinasesCYCLACEL LTD·Filed 2006·Granted Aug 18, 2009·7 cites·17 claims
- 1079US11162083B2Peptide based inhibitors of Raf kinase protein dimerization and kinase activityUNIV SOUTH CAROLINA·Filed 2019·Granted Nov 2, 2021·2 cites·20 claims
- 1178US7432260B2Pyrimidine compoundsCYCLACEL LIMTED·Filed 2004·Granted Oct 7, 2008·17 cites·34 claims
- 1276US7449544B2p21 peptidesCYCLACEL LTD·Filed 2003·Granted Nov 11, 2008·11 cites·9 claims
- 1374US12415822B2Small molecule inhibitors selective for polo-like kinase proteinUNIV SOUTH CAROLINA·Filed 2023·Granted Sep 16, 2025·0 cites·13 claims
- 1467US11597737B2Small molecule inhibitors selective for polo-like kinase proteinsUNIV SOUTH CAROLINA·Filed 2020·Granted Mar 7, 2023·0 cites·12 claims
- 1563US2023338316A1Abbapolins as inhibitors and degraders of polo-like kinasesUNIV SOUTH CAROLINA·Filed 2023·Application pending·0 cites
- 1661US11712437B2Inhibitors of lysyl oxidasesUNIV SOUTH CAROLINA·Filed 2022·Granted Aug 1, 2023·0 cites·20 claims
- 1761US2024075015A1Inhibitors of Lysyl OxidasesUNIV SOUTH CAROLINA·Filed 2023·Application pending·0 cites
- 1859US2025127906A1Small-molecule degraders of cdk8 and cdk19UNIV SOUTH CAROLINA·Filed 2022·Application pending·0 cites
- 1958US12281080B2Quinoline-based compounds and methods of inhibiting CDK8/19UNIV SOUTH CAROLINA·Filed 2021·Granted Apr 22, 2025·0 cites·19 claims
- 2057US2017283445A1Small Molecule Inhibitors Selective For Polo-Like Kinase ProteinsUNIV SOUTH CAROLINA·Filed 2017·Application pending·0 cites
- 2153US2016011195A1Method of Forming Fragment Ligated InhibitorsUNIV SOUTH CAROLINA·Filed 2015·Application pending·0 cites
- 2252US2013289240A1Cyclin Based Inhibitors of CDK2 and CDK4MCINNES CAMPBELL·Filed 2013·Application pending·0 cites
- 2347US2006293245A1P21 derived peptides and uses thereofCYCLACEL LTD·Filed 2006·Application pending·0 cites
- 2447US2022226343A13-amino-4-[4-[4 (dimethylcarbamoyl) phenyl]-1,4-diazepan-1-yl]thieno[2,3-b]pyridine-2-carboxamide for use in cancer therapy and formulations comprising the sameUNIV SOUTH CAROLINA·Filed 2020·Application pending·0 cites
- 2545US11572369B2Bicyclic pyridine compositions and methods of using the same for cancer therapyUNIV SOUTH CAROLINA·Filed 2020·Granted Feb 7, 2023·0 cites·20 claims
- 2644US2019269784A1Selective Inhibitors of the Polo-Like Kinase 1 Polo-Box DomainUNIV SOUTH CAROLINA·Filed 2019·Application pending·0 cites
- 2743US2006281687A1Cyclin groove inhibitorsANDREWS MARTIN J·Filed 2006·Application pending·0 cites
- 2843US2009215805A14-Heteroaryl Pyrimidine Derivatives and use thereof as Protein Kinase InhibitorsCYCLACEL LTD·Filed 2006·Application pending·0 cites
- 2943US2014296484A1Cyclin Based Inhibitors of CDK2 and CDK4UNIV SOUTH CAROLINA·Filed 2013·Application pending·0 cites
- 3042US2008132484A1Method for Identifying Inhibitors Using a Homology Model of Polo-Like Kinase 1CYCLACEL LTD·Filed 2004·Application pending·0 cites
- 3139US2003036628A1p21 peptidesFiled 2000·Application pending·0 cites
- 3237US2006040997A1Benzthiazole-3 oxides useful for the treatment of proliferative disordersMCINNES CAMPBELL·Filed 2005·Application pending·0 cites
- 3334US2008167385A1Crystal Structure of Human Proliferating Cell Nuclear Antigen (Pcna) and Uses ThereofKONTOPIDIS GEORGE·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Campbell Mcinnes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →